What's in LimmaTech Biologics AG's pipeline?

LimmaTech Biologics AG has 10 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 7 in Phase 1.

Which companies overlap with LimmaTech Biologics AG's portfolio?

Top competitors by shared drug class: Pfizer, GlaxoSmithKline, Merck Sharp & Dohme LLC, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/limmatech-biologics-ag.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

LimmaTech Biologics AG — Portfolio Competitive Intelligence Brief

LimmaTech Biologics AG pipeline: 1 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 2 Phase 2 7 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
MenACWY	MenACWY	marketed	Conjugate vaccine	Neisseria meningitidis serogroups A, C, W, Y polysaccharide capsules	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Merck Sharp & Dohme LLC · 2 shared drug classes
National Institute of Allergy and Infectious Diseases (NIAID) · 2 shared drug classes
Sanofi · 2 shared drug classes
Amgen · 1 shared drug class
Akeso · 1 shared drug class
ATGC Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for LimmaTech Biologics AG:

Cite this brief

Drug Landscape (2026). LimmaTech Biologics AG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/limmatech-biologics-ag. Accessed 2026-05-16.